Stefanie S. Jeffrey

机构：Sarcoma Oncology Center · ORCID：0000-0003-4478-2764

发表论文 246 篇 · 总被引 48130 次 · h-index 62

代表论文

• Rapid genetic screening with high quality factor metasurfaces (2023 · Nature Communications · 被引 55)
• Inhibition of protein translational machinery in triple-negative breast cancer as a promising therapeutic strategy (2024 · Cell Reports Medicine · 被引 24)
• Rapid genetic screening with high quality factor metasurfaces (2023 · PubMed · 被引 2)
• 1739P Linnovate: A phase I/II study of safety/efficacy using lurbinectedin combined with ipilimumab and nivolumab for advanced soft tissue sarcoma (NCT05876715) - Interim analysis of phase I part (2024 · Annals of Oncology · 被引 1)
• 1733P Update on gallant: A phase II study using metronomic gemcitabine, doxorubicin and docetaxel plus nivolumab in previously treated sarcoma (2024 · Annals of Oncology · 被引 1)
• 2706P Clinical benefit analysis of a phase I/II study using lurbinectedin combined with ipilimumab and nivolumab as first-line therapy for advanced soft tissue sarcoma (NCT05876715) (2025 · Annals of Oncology)